300550.SHE Heren Health Co Ltd
- Market cap
- CNY 3.20B
- P/E
- -
- P/B
- 2.72x
- ROE
- -7.7%
- Dividend yield
- 0.28%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300550.SHE undervalued?
Graham numberThe Graham number of Heren Health Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Heren Health Co Ltd fundamental analysis
No fundamental analysis for Heren Health Co Ltd yet.
Heren Health Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Heren Health Co Ltd
Heren Health Co.,Ltd. provides medical solutions to hospitals and governments in China. The company offers solutions to smart hospitals, healthy city, smart medical consortium, and medical treatment. Heren Health Co.,Ltd. was founded in 2010 and is headquartered in Hangzhou, China.
Full company profileHeren Health Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Heren Health Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 236M | 276M | 391M | 441M | 455M | 464M | 360M | 439M | 406M | 435M | 289M |
| Gross Profit | 131M | 133M | 180M | 201M | 196M | 161M | 73.7M | 169M | 188M | 203M | 65.0M |
| Operating Income | 50.6M | 46.8M | 64.2M | 67.1M | 77.9M | 41.8M | -56.9M | 47.0M | 75.4M | 84.3M | -74.2M |
| EBITDA | - | 49.7M | 57.7M | 62.4M | 63.7M | 57.1M | -61.3M | 77.5M | 77.2M | 81.3M | -93.2M |
| Net Income | 52.1M | 32.9M | 40.4M | 41.2M | 43.1M | 34.8M | -83.3M | 39.1M | 39.3M | 47.7M | -83.7M |
| EPS | - | 0.21 | 0.25 | 0.25 | 0.23 | 0.13 | -0.32 | 0.15 | 0.15 | 0.18 | -0.32 |
| Balance Sheet | |||||||||||
| Total Assets | 589M | 693M | 944M | 953M | 1.56B | 1.52B | 1.43B | 1.44B | 1.46B | 1.50B | 1.39B |
| Total Liabilities | 103M | 178M | 386M | 323M | 437M | 359M | 386M | 358M | 342M | 320M | 278M |
| Shareholders' Equity | 480M | 505M | 547M | 618M | 1.10B | 1.13B | 1.04B | 1.08B | 1.11B | 1.15B | 1.08B |
| Cash & Short-term Investments | 129M | 117M | 365M | 300M | 440M | 456M | 506M | 555M | 542M | 533M | 343M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 15.9M | 44.7M | 18.2M | 41.4M | -67.6M | -18.0M | -89.2M | 83.4M | 8.00M | 126M | - |
| Capital Expenditure | 45.9M | 38.4M | 17.3M | 17.7M | 63.5M | 76.4M | 37.1M | 24.9M | 45.9M | 42.0M | 36.0M |
| Free Cash Flow | - | 6.32M | 899K | 23.7M | -131M | -94.2M | -126M | 58.5M | -37.9M | 83.9M | -146M |
| Ratios | |||||||||||
| ROE | 10.8% | 6.5% | 7.4% | 6.7% | 3.9% | 3.1% | -8.0% | 3.6% | 3.5% | 4.1% | -7.7% |
| ROA | 8.8% | 4.7% | 4.3% | 4.3% | 2.8% | 2.3% | -5.8% | 2.7% | 2.7% | 3.2% | -6.0% |
| Net Profit Margin | 22.1% | 11.9% | 10.3% | 9.4% | 9.5% | 7.5% | -23.1% | 8.9% | 9.7% | 11.0% | -29.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Heren Health Co Ltd dividends
- Dividend yield
- 0.28%
- Forward dividend
- 0.03 CNY
- Payout ratio
- 18.6%
- Ex-dividend date
- Jun 15, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 8.87M | 0.03 | 18.6% |
| 2024 | CNY 12.1M | 0.05 | 30.9% |
| 2023 | CNY 4.41M | 0.02 | 11.3% |
| 2022 | CNY 8.90M | 0.03 | - |
| 2021 | CNY 8.86M | 0.03 | 25.5% |
| 2020 | CNY 10.5M | 0.06 | 24.3% |
| 2019 | CNY 10.6M | 0.06 | 25.8% |
| 2018 | CNY 7.41M | 0.05 | 18.3% |
| 2017 | CNY 8.67M | 0.06 | 26.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.4:1 on Jun 16, 2021.
Who owns Heren Health Co Ltd
- Insiders 56.47%
- Institutions 1.08%
- Public & others 42.45%
- Shares outstanding 263M
- Free float 146M
Heren Health Co Ltd company profile
- Company name
- Heren Health Co Ltd
- Ticker
- 300550.SHE
- ISIN
- CNE100002D53
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 794
- Fiscal year end
- December
- Address
- No. 625, Xinlian Road, Hangzhou, China, 310051
- Phone
- 86 57 1813 97000
- Website
- herenit.com
About Heren Health Co Ltd
Heren Health Co.,Ltd. provides medical solutions to hospitals and governments in China. The company offers solutions to smart hospitals, healthy city, smart medical consortium, and medical treatment. Heren Health Co.,Ltd. was founded in 2010 and is headquartered in Hangzhou, China.
Heren Health Co Ltd management
4- Mr. Chenhui ZhaoChairman & GM · born 1979
- Ms. Shuangshuang LiuFinancial Manager · born 1986
- Ms. Yi ZhangDeputy GM & Secretary of the Board of Directors · born 1984
- Shixiao FuAccounting Supervisor